Skip to main navigation Skip to search Skip to main content

Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: Outcome by intensity of conditioning

  • Paul A. Veys
  • , Vasanta Nanduri
  • , K. Scott Baker
  • , Wensheng He
  • , Giuseppe Bandini
  • , Andrea Biondi
  • , Arnaud Dalissier
  • , Jeffrey H. Davis
  • , Gretchen M. Eames
  • , R. Maarten Egeler
  • , Alexandra H. Filipovich
  • , Alain Fischer
  • , Herbert Jürgens
  • , Robert Krance
  • , Edoardo Lanino
  • , Wing H. Leung
  • , Susanne Matthes
  • , Gérard Michel
  • , Paul J. Orchard
  • , Anna Pieczonka
  • Olle Ringdén, Paul G. Schlegel, Anne Sirvent, Kim Vettenranta, Mary Eapen

Research output: Contribution to journal › Article › peer-review

Abstract

Patients with Langerhans cell histiocytosis (LCH) refractory to conventional chemotherapy have a poor outcome. There are currently two promising treatment strategies for high-risk patients: the first involves the combination of 2-chlorodeoxyadenosine and cytarabine; the other approach is allogeneic haematopoietic stem cell transplantation (HSCT). Here we evaluated 87 patients with high-risk LCH who were transplanted between 1990 and 2013. Prior to the year 2000, most patients underwent HSCT following myeloablative conditioning (MAC): only 5 of 20 patients (25%) survived with a high rate (55%) of transplant-related mortality (TRM). After the year 2000 an increasing number of patients underwent HSCT with reduced intensity conditioning (RIC): 49/67 (73%) patients survived, however, the improved survival was not overtly achieved by the introduction of RIC regimens with similar 3-year probability of survival after MAC (77%) and RIC transplantation (71%). There was no significant difference in TRM by conditioning regimen intensity but relapse rates were higher after RIC compared to MAC regimens (28% vs. 8%, P = 0·02), although most patients relapsing after RIC transplantation could be salvaged with further chemotherapy. HSCT may be a curative approach in 3 out of 4 patients with high risk LCH refractory to chemotherapy: the optimal choice of HSCT conditioning remains uncertain.

Original languageEnglish (US)
Pages (from-to)711-718
Number of pages8
JournalBritish journal of haematology
Volume169
Issue number5
DOIs
StatePublished - Jun 1 2015

Bibliographical note

Publisher Copyright:
© 2015 John Wiley & Sons Ltd.

Keywords

  • Allogeneic transplantation
  • Conditioning regimen intensity
  • Langerhans cell histiocytosis
  • Survival
  • Treatment failure

Fingerprint

Dive into the research topics of 'Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: Outcome by intensity of conditioning'. Together they form a unique fingerprint.

Cite this